General Information
Product name
Norepinephrine Bitartrate Inj. USP
Manufacturer Name
Hospital Products Division
Emergency telephone
1-847-937-7970, 1-800-424-9300
Icons in SDS
Company Information
company name
Hospital Products Division
Section 2
Principle Routes of Exposure
Skin: Yes 3. HAZARDS INFORMATION, continued ----------------------- Inhalation: Yes Ingestion: Yes INGESTION RATING: Highly toxic SKIN ABSORPTION RATING: Toxic INHALATION RATING: N/D CORROSIVENESS RATING: N/D SKIN CONTACT RATING: N/D SKIN SENSITIZATION RATING: N/D EYE CONTACT RATING: Possible irritant TARGET ORGANS: Cardiovascular system, nervous system, reproductive system, fetus. CARCINOGENICITY RATING NTP N/L IARC N/L OSHA N/L ACGIH: N/L None SIGNS AND SYMPTOMS: N/D. In clinical use, norepinephrine can produce many side effects including slowed heart rate, restlessness, palpitations, tremors, weakness, headache, elevated blood pressure, arrythmias, and electrolyte imbalance. Chronic inhalation could result in nasal congestion. MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: N/D. Clinical data suggest cardiovascular disease, blood volume deficiencies, or thrombotic ailments. Concurrent use of monoamine oxidase inhibitors or use in conjunction with cyclopropane or halothane anesthesia. Hypersensitivity to sympathomimetic amine, blood volume deficiencies, or thrombotic ailments.
